Fig. 5
From: Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy
The melittin-MIL-2 treatment shaped a local immunostimulatory microenvironment. a The level of IFN-γ significantly increased in the treated mice with melittin-MIL-2 compared to PBS group (p < 0.05). c The level of IL-4 significantly reduced in the treated mice with melittin-MIL-2 compared to PBS group (p < 0.05). b, d No significant change was observed in quantity of IL-12 and TNF-α among mice treated melittin-MIL-2